Cargando…
The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular disease
Nonalcoholic fatty liver disease (NAFLD) is a chronic metabolic disease characterized by an excessive accumulation of fat in the liver, which is becoming a major global health problem, affecting about a quarter of the population. In the past decade, mounting studies have found that 25%–40% of NAFLD...
Autores principales: | Qin, Li, Wu, Junru, Sun, Xuejing, Huang, Xuewei, Huang, Wei, Weng, Chunyan, Cai, Jingjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169694/ https://www.ncbi.nlm.nih.gov/pubmed/37180779 http://dx.doi.org/10.3389/fcvm.2023.1119005 |
Ejemplares similares
-
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
por: Finney, Alexandra C., et al.
Publicado: (2023) -
Editorial: The regulatory role of metabolic organ-secreted factors in the development of cardiovascular diseases
por: You, Mei, et al.
Publicado: (2023) -
Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and atherosclerosis
por: Mo, Shuangyang, et al.
Publicado: (2023) -
Effect of Early Pharmacologic Cardioversion vs. Non-early Cardioversion in the Patients With Recent-Onset Atrial Fibrillation Within 4-Week Follow-Up Period: A Systematic Review and Network Meta-Analysis
por: Tang, Yan, et al.
Publicado: (2022) -
The projections of global and regional rheumatic heart disease burden from 2020 to 2030
por: Hu, Yingying, et al.
Publicado: (2022)